Original article by Jemima Whyte, Joanna Heath, Jessica Gardner
The Australian Financial Review – Page: 1 & 4 : 28-Aug-14

Some business leaders are publicly supporting the Australian Government’s $A20 billion Medical Research Future Fund. UBS CEO Matthew Grounds, Wesfarmers CEO Richard Goyder and ASX CEO Elmer Funke Kupper are concerned that the measure will not be passed by the Senate. They said that it will provide social and commercial benefits for Australia, attracting capital and making the health sector more profitable

CORPORATES
WESFARMERS LIMITED – ASX WES, ASX LIMITED – ASX ASX, UBS HOLDINGS PTY LTD, AUSTRALIAN MOTORING ENTHUSIAST PARTY, AUSTRALIA. DEPT OF HEALTH, HEALTHSCOPE LIMITED – ASX HSO